Edition:
United States

Dignitana AB (DIGN.ST)

DIGN.ST on Stockholm Stock Exchange

14.40SEK
18 Aug 2017
Change (% chg)

0.00kr (+0.00%)
Prev Close
14.40kr
Open
14.40kr
Day's High
14.40kr
Day's Low
14.00kr
Volume
12,121
Avg. Vol
16,328
52-wk High
20.90kr
52-wk Low
10.70kr

DIGN.ST

Chart for DIGN.ST

About

Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold... (more)
No analyst recommendations are available for DIGN.ST.

Overall

Beta: -0.09
Market Cap(Mil.): kr291.95
Shares Outstanding(Mil.): 20.27
Dividend: --
Yield (%): --

Financials

  DIGN.ST Industry Sector
P/E (TTM): -- 30.22 32.70
EPS (TTM): -1.55 -- --
ROI: -83.45 13.77 14.88
ROE: -83.45 16.61 16.12

BRIEF-Dignitana continues U.S. growth with ten new orders

* DIGNITANA CONTINUES U.S. GROWTH WITH TEN NEW ORDERS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 10 2017

BRIEF-Dignitana enters into cooperation with Piedmont Cancer Institute

* DIGNITANA ENTERS INTO COOPERATION WITH PIEDMONT CANCER INSTITUTE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 09 2017

BRIEF-Dignitana Q1 net sales up at SEK 6.1 million

* Q1 NET SALES SEK 6.1 MILLION VERSUS SEK 1.1 MILLION YEAR AGO

May 24 2017

BRIEF-Dignitana announces availability of DigniCap system in seven additional sites in U.S.

* ANNOUNCED TODAY AVAILABILITY OF DIGNICAP® SYSTEM IN SEVEN ADDITIONAL SITES ACROSS U.S. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

May 23 2017

BRIEF-Dignitana Q4 pretax loss widens to 11.6 million crowns

* Q4 net sales 4.1 million Swedish crowns ($455,000) versus 277,000 crowns year ago

Feb 23 2017

Earnings vs. Estimates

No consensus analysis data available.